Loss in CTCF copy number occurred in 7.0% of endometrioid and 65.5% of serous subtype tumours, indicating that CTCF genetic deletion was more common in poorer prognosis serous subtype tumours (Fisher’s exact test, P<0.001; Figure 2c). The gene discussed is CTCF; the disease is neoplasm.